Barton Debora 4
4 · TScan Therapeutics, Inc. · Filed Feb 6, 2023
Insider Transaction Report
Form 4
Barton Debora
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-02+50,000→ 50,000 totalExercise: $1.81Exp: 2033-02-01→ Voting Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option vest over 4 years of service following February 2, 2023, with 25% vesting upon completion of 1 year of continuous service to the Issuer and the balance vesting in 36 equal monthly installments thereafter.